• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氨氯地平吸收、分布、代谢和排泄的临床后果。

The clinical consequences of the absorption, distribution, metabolism and excretion of amlodipine.

作者信息

Elliott H L, Meredith P A

机构信息

Department of Medicine and Therapeutics, Stobhill General Hospital, Glasgow, UK.

出版信息

Postgrad Med J. 1991;67 Suppl 3:S20-3.

PMID:1836870
Abstract

By comparison with other calcium antagonist drugs, amlodipine has unique pharmacokinetic properties that are probably attributable to its chemical structure and positive ionic charge at physiological pH. Thus, amlodipine undergoes gradual absorption from the gastro-intestinal tract and is widely distributed throughout body tissues. It is cleared only slowly by metabolism in the liver and so has a long elimination half-life, which makes it suitable for single daily dosing. During steady-state administration there are only small peak-to-trough variations in plasma drug levels and in clinical use these pharmacokinetic properties appear to be associated with a smoother pharmacodynamic effect and a reduced incidence of (early) vasodilator side effects.

摘要

与其他钙拮抗剂药物相比,氨氯地平具有独特的药代动力学特性,这可能归因于其化学结构以及在生理pH值下的正离子电荷。因此,氨氯地平从胃肠道逐渐吸收,并广泛分布于全身组织。它仅通过肝脏代谢缓慢清除,因此消除半衰期长,这使其适合每日单次给药。在稳态给药期间,血浆药物水平仅存在小的峰谷波动,在临床应用中,这些药代动力学特性似乎与更平稳的药效学效应以及(早期)血管扩张剂副作用发生率降低相关。

相似文献

1
The clinical consequences of the absorption, distribution, metabolism and excretion of amlodipine.氨氯地平吸收、分布、代谢和排泄的临床后果。
Postgrad Med J. 1991;67 Suppl 3:S20-3.
2
Amlodipine: a once daily calcium antagonist.氨氯地平:一种每日服用一次的钙拮抗剂。
J Hum Hypertens. 1991 Aug;5 Suppl 1:49-54.
3
[Amlodipine: pharmacokinetic and pharmacodynamic profile of a calcium antagonist with prolonged effect].氨氯地平:一种具有长效作用的钙拮抗剂的药代动力学和药效学特征
Schweiz Rundsch Med Prax. 1992 Feb 11;81(7):199-203.
4
Clinical pharmacokinetics of amlodipine.
Clin Pharmacokinet. 1992 Jan;22(1):22-31. doi: 10.2165/00003088-199222010-00003.
5
Nilvadipine: profile of a new calcium antagonist. An overview.尼伐地平:一种新型钙拮抗剂的概况。综述。
J Cardiovasc Pharmacol. 1994;24 Suppl 2:S92-107.
6
Pharmacokinetics and pharmacodynamics of amlodipine.
Cardiology. 1992;80 Suppl 1:31-6. doi: 10.1159/000175050.
7
[Amlodipin (Norvasc). A new calcium antagonist with long half-life].氨氯地平(络活喜)。一种新型半衰期长的钙拮抗剂
Tidsskr Nor Laegeforen. 1991 Jun 20;111(16):1981-2.
8
Amlodipine: pharmacokinetic profile of a low-clearance calcium antagonist.
J Cardiovasc Pharmacol. 1991;17 Suppl 1:S4-7.
9
The pharmacological profile of amlodipine in relation to ischaemic heart disease.氨氯地平在缺血性心脏病方面的药理学特性。
Postgrad Med J. 1991;67 Suppl 3:S9-15.
10
Clinical evaluation of amlodipine, a new long-acting calcium antagonist, in mild and moderate hypertension.新型长效钙拮抗剂氨氯地平治疗轻、中度高血压的临床评价
Int J Clin Pharmacol Res. 1991;11(5):243-6.

引用本文的文献

1
Model-Informed Precision Dosing of Levamlodipine Besylate in Smoking Patients.吸烟患者中苯磺酸左旋氨氯地平的模型指导精准给药
Drug Des Devel Ther. 2025 Apr 24;19:3193-3207. doi: 10.2147/DDDT.S501762. eCollection 2025.
2
Optimization of Personalized Amlodipine Dosing Strategies for Children Based on Pharmacokinetic Data from Chinese Male Adults and PBPK Modeling.基于中国成年男性药代动力学数据和生理药代动力学模型的儿童氨氯地平个体化给药策略优化
Children (Basel). 2021 Oct 22;8(11):950. doi: 10.3390/children8110950.
3
Amlodipine. A reappraisal of its pharmacological properties and therapeutic use in cardiovascular disease.
氨氯地平。对其药理特性及在心血管疾病治疗应用的重新评估。
Drugs. 1995 Sep;50(3):560-86. doi: 10.2165/00003495-199550030-00009.